In some cancers, such as prostate and rectal adenocarcinomas, TMPRSS2 is overexpressed and associated with better immune responses, and correlates with poor outcomes and enhanced tumor aggressiveness. The gene discussed is TMPRSS2; the disease is neoplasm.